Introduction

Several subsets of CD4
+ T h cells have been described, but the two originally defined and best understood are the IFN-γ-producing T h 1 subset and the IL-4-producing T h 2 subset (1) (2) (3) (4) (5) . The primary function of the T h 1 cells is to protect the host from intracellular pathogen infections. T h 2 cells protect against multicellular helminths, but the IgE that is an important component of this response is commonly associated with allergies, particularly in developed countries (1, (6) (7) (8) (9) . A pathogen infection may induce a shift of the T h 1/2 cell balance, leading to a T h 1 dominant status. This, in turn, results in the suppression of T h 2 induction. Induction of the T h 1 subset requires IL-12, and the activation of the Il12p40 gene is controlled mainly by the transcription factors interferon regulatory factor-1 (IRF-1) and NF-κB (10) (11) (12) .
In previous studies, we focused on the induction of T h 1 cells in Irf1 gene-targeted mice responding to various pathogens. Heat-killed Listeria monocytogenes (Lm) and fixation-attenuated Bordetella pertussis failed to induce the T h 1 cells in IRF-1-deficient mice; instead these attenuated pathogens induced robust T h 2 response. The same failure of T h 1 induction was also observed in these mice in response to LPS plus IFN-γ. However, Leishmania major induced a T h 1 response and Plasmodium berghei induced an even stronger T h 1 response in the knockout mice (13) . In addition, a T h 2 response to these pathogens was also observed. These observations suggested that the induction of T h 1 and the inhibition of the T h 2 shift observed during pathogen infections are mediated by separate mechanisms that have not yet been clarified. In addition, the mechanism that induces the T-cell subset shift during pathogen infection in the IRF-1-deficient mice is different from the mechanism that induces the shift following protein antigen immunization, which is also observed in these mice (11) . Together these observations suggest that IRF-1 may be involved in the inhibition of the T h 2 shift.
Several transcription factors, cis-acting repressor and silencer elements (3ʹ untranslated region [3ʹUTR]), as well as epigenetic modifications, regulate expression of the Il4 gene (14) (15) (16) (17) (18) (19) (20) . A consensus IRF-1 binding sequence is found in the 3ʹUTR sequence of the Il4 gene (Figure 4 of ref. 18) , which prompted us to investigate the role of IRF-1 in Il4 gene expression during pathogen infections. In this study, we have focused on the mechanism of the suppression of T h 2 induction during Lm infection. We found that the IL-4-production by T h 2 cells is inhibited by IL-1 produced by the Lm-infected antigen-presenting cells (APCs). Under the influence of IL-1, IRF-1 binds to the 3ʹUTR region of the Il4 gene and down-regulates its transcription. On the basis of these results, we propose that IRF-1 functions to induce the shift to T h 1 dominance via two different mechanisms (10) (11) (12) 21) . Therefore, the immune response shifts predominantly to T h 1 during Listeria infection, resulting in the effective protection of the host.
Methods
Cytokines and reagents
Recombinant murine IL-1α and IL-1β were purchased from PeproTech Inc. (Rocky Hill, NJ, USA). Antibody specific for IRF-1 protein was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-CD3 mAb (145-2C11) was purified from ascites of 2C11 cells (22) . Anti-CD28 mAb (PV-1) (23) was a kind gift from Dr R. Abe (Tokyo University of Science, Chiba, Japan). Anti-IL-1R antibody was purchased from R&D systems (Minneapolis, MN, USA). Anti-IL-1α and anti-IL-1β antibodies were purchased from BioLegend Inc. (San Diego, CA, USA). Cytokines and antibodies were used at a concentration of 10 ng ml −1 and 10 μg ml −1 , respectively.
Mice
BALB/c and C57BL/6 (B6) mice were purchased from Charles River Japan Inc. (Yokohama, Japan). DO11.10 ovalbumin (OVA)-peptide-specific TCR-Tg mice were developed by Dr D. Loh (24) . The TCR-Tg mice were crossed to BALB/c mice for more than 10 generations. Irf1 gene disrupted mice (C57BL/6JJcl-Irf1 tm1 ) were provided by Dr T. Taniguchi (University of Tokyo, Tokyo, Japan) (25) . Irf1 gene disrupted mice on the BALB/c background were generated by backcrossing to BALB/c mice for more than 10 generations. Il12p40 gene disrupted mice on the a BALB/c background (BALB/c-[KO] IL12p40 N5) were provided by Dr R. H. Schwartz (National Institutes of Health, Bethesda, MD, USA) (26) . Mice and their littermates were reared under specific pathogen-free conditions in the animal facility of the Ehime University Graduate School of Medicine. All mice were used in accordance with the institutional guides for animal experimentation.
Pathogens
Lm (LO28 strain) was provided by Dr P. Cossart (Pasteur Institute, Paris, France). For in vivo infection experiments, 1 × 10 3 of bacteria were inoculated intra-peritoneally (27) .
T-cell clones
The T h 2 T-cell clone MS-SB is a derivative of an autoreactive T h clone of C3H origin (MS202) and the T h 2 clone 24-2M and 8-5T are derivatives of antigen-specific A b -restricted T h clone of (B6 × C3H) F1 origin. The T h 1 T-cell clone 9-16M is a derivative of an antigen-specific E k -restricted T h clone of (B6 × C3H) F1 origin and the T h 1 clone 28-4M is a derivative of an antigen-specific A k -restricted Th clone of (B6 × C3H) F1 origin (28) (29) (30) (31) .
In vitro infection with Lm and preparation of LmSN
For in vitro infection, spleen cells were infected with Lm at an multiplicity of infection (MOI) of 5 for 1 h followed by the addition of antibiotics (27) . T-depleted spleen cells were prepared by depleting T cells with anti-T-cell antibody and complement as described previously (28, 32) . T-depleted spleen cells of BALB/c origin (1 × 10 7 cells/ml) were infected with Lm at an MOI of 5 for 1 h. One day after infection, the culture supernatant was harvested, centrifuged, filtered through a 0.22-μm filter and used as the infected supernatant (LmSN).
In vitro stimulation of spleen cells
Spleen cells obtained from mice infected or uninfected with Lm were stimulated in vitro with anti-CD3 mAb plus anti-CD28 mAb (27) at a concentration of 1 × 10 7 cells per well in 24-well plates for 1 day at 37°C in a 5% CO 2 humidified air atmosphere. On the next day, the cytokines in the culture supernatant were determined by ELISA. The medium used was RPMI1640 supplemented with 2 mM l-glutamine, 100 U ml −1 penicillin, 100 μg ml −1 streptomycin, 1 mM sodium pyruvate, 1× non-essential amino acids, 50 μM 2-mercaptoethanol and 10% heat-inactivated FCS. DO11.10 Tg spleen cells were stimulated in vitro with 20 μM of OVA peptide for 5 days in the presence or absence of LmSN. The cultured cells were restimulated with plate-coated anti-TCRβ antibody (H57-597, a kind gift from Dr R. T. Kubo, National Jewish Center, Denver, CO, USA) (33) and the amount of cytokines in the culture supernatant was determined by ELISA.
In vitro stimulation of cloned T cells
The cloned cells were cultured at a concentration of 1 × 10 6 cells per well in 24-well plates in the presence or absence of LmSN for 1 day. The cultures were stimulated with PMA (Wako Pure Chemical Industries, Osaka, Japan; 50 ng ml −1 ) plus ionophore (A23187, Wako Pure Chemical Industries) (500 ng ml −1 ) (P/I) or plate-coated anti-TCRβ antibody where stated. The amount of cytokines in the culture supernatant was determined by ELISA.
Preparation of in vitro induced primary T cells
CD4 + spleen cells were prepared using anti-CD4 antibodycoated microbeads and MACS Separation columns (Miltenyi Biotec), and were stimulated in vitro with plate-coated anti-TCR antibody and anti-CD28 antibody. Two days after initial stimulation, cells were transferred into new wells and further cultured for 4 days in the presence of IL-2. These cultured cells were used as a source of primary T cells. In the particular experiments, primary T cells were induced under T h 1-inducing conditions (with anti-IL-4 antibody and recombinant IL-12) and T h 2-inducing conditions (with anti-IFN-γ and recombinant IL-4).
Plasmids and electroporation
A luciferase reporter plasmid containing the Il4 gene promoter region (pIL4-pGL4) and an IRF-1 expression plasmid (pAct-1) (34) were provided by Dr M. Kubo, Tokyo University of Science and Dr T. Taniguchi, University of Tokyo, respectively. A DNA segment of the Il4 3ʹUTR region (1.2 kb) was obtained by PCR using MS-SB genomic DNA as a template and engineered into pIL4-pGL4 (pIL4-pGL4-3ʹUTR). Plasmids were transfected into T h cells by Cell-Porator (BRL, Gaithersburg, MD, USA) using the protocol recommended by the manufacturer.
Cytokine ELISA
IFN-γ, IL-4 and IL-5 in the culture supernatant were detected by sandwich ELISA established with mAb that were purchased from PharMingen (San Diego, CA, USA). Recombinant mouse proteins were purchased from Genzyme (Cambridge, MA, USA) and were used as standards (11, 13, 27) .
Quantitative PCR
Total RNA was prepared from infected or untreated cells at 4 h p.i. using Trizol reagent (Invitrogen) according to the manufacturer's protocol. Extracted RNA was treated with DNase I to eliminate genomic DNA. Equal amounts of RNA (1 μg) were reverse transcribed using 200 U of reverse transcriptase (Moloney murine leukemia virus; Promega, Madison, WI, USA), 1 mM of dNTP and 100 ng of random primers (Takara Shuzo, Kyoto, Japan) in a total volume of 20 μl. Sequences for primers used were: β-actin, 5ʹ-ATGG GTCAGAAGGACTC C-3ʹ and 5ʹ-CCCAAGAAGGAAGGCTGG-3ʹ; Cα, 5ʹ-CATCCAGAA CCCAGAACC-3ʹ and 5ʹ-CGGAACTTGGAAGTCAGGC-3ʹ; IL-4, 5ʹ-TCCTGCTCTTCTTT CTC GAA TG TACC-3ʹ and 5ʹ-ACGAG TAATCCATTTGCATGATGCTC-3ʹ; pre-mRNA of IL-4, set 1, 5ʹ-TCC TGCTCTTCTTTCTCGAATGTACC-3ʹ and 5ʹ-TTGTGTG TCTCCTAT GAT CT AGAT-3ʹ and set 2, 5ʹ-GCTAGTTGTCATC CTGCTCT -3ʹ and 5ʹ-TGTCCCTAGT CCTG CCTCAG -3ʹ; IL-5, 5ʹ-CAGTGGTGAAAGAGACCTTGAC-3ʹ and 5ʹ-GAACTCT TG CAGGTAATCCA GGAA-3ʹ; IL-13, 5ʹ-GCTCTGGGTGACTGC AGTCCTG-3ʹ and 5ʹ-CAGTTGCTTTGTG TAGCTGAGCAG-3ʹ; IRF-1, 5ʹ-CGGATGAGACCCTGGCT AG AGATGCAG-3ʹ and 5ʹ-GGGTAGAGCTGCTGAGTCCATCAGAG-3ʹ; GATA3, 5ʹ-AT GGAAGCTCAGTATCCGC-3ʹ and 5ʹ-TCCAGCCAGGGCAGAG ATC-3ʹ; T-bet, 5ʹ-GGGGTTGGAGGTGTCTGGGA-3ʹ and 5ʹ-C AAG CAGTT GACAG TTGGG TCCAG G-3ʹ. The quantitative PCR (qPCR) was performed by using the 7500 real-time PCR system (Applied Biosystems).
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assay was carried out as described previously (10) . MS-SB cells were cultured with or without LmSN and stimulated with P/I. Four hours later, formaldehyde solution was added directly to the culture at a final concentration of 1%. Cross-linking of proteins on chromatin was allowed to occur at 37°C for 10 min, and the cells were lysed sequentially with Nonidet P-40 lysis buffer and SDS lysis buffer with protease inhibitors. Chromatin in the lysate was sonicated to an average length of 500-1000 bp as determined by agarose gel electrophoresis. IRF-1 protein binding to chromatin was immunoprecipitated, washed and eluted. Cross-links were reversed by 0.5 M NaCl. After proteinase K digestion, DNA in samples was phenol extracted, ethanol precipitated and used for qPCR amplification to detect the Il4 gene 3ʹUTR segment. PCR primers used for detection of the Il4 gene 3ʹUTR segment were: 5ʹ-TACTGTTAGAGAAAGCATTTAG-3ʹ and 5ʹ-CCTACAGGCA TGTGGTCTGTGTAC-3ʹ.
Immunoblotting
Cytoplasmic and nuclear extracts were prepared using the NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific, Waltham, MA, USA). The antibodies used for the immunoblot analysis were anti-IRF-1 anti-sera (sc-640×; Santa Cruz), anti-α tubulin mAb (DM1A; Pierce Biotechnology, Rockford, IL, USA).
Statistical analysis
The unpaired t-test was used for statistical analysis.
Results
IL-12 is required for the production of IFN-γ, while IRF-1 is required for the inhibition of IL-4 production
IL-12 is a key cytokine for inducing T h 1 T cells, and the transcription of the Il12b gene is regulated by IRF-1 (10, 11). However, even in the IRF-1-deficient mice, L. major induced a T h 1 response to some extent, and P. berghei elicited an even stronger T h 1 response (13). In the same experiments, we noticed that IL-4 production by the spleen cells of IRF-1-deficient mice was not suppressed but rather augmented by pathogen infection (13) . These results suggest that IRF-1 is involved in regulating not only the T h 1-subset induction but also the T h 2 subset suppression (13, 20) .
In this study, we used Lm to evaluate the role of IRF-1 in the induction of T h subsets (Fig. 1) . The indicated mice were infected intra-peritoneally with 1 × 10 3 Listeria, and 3 days later, the spleen cells were stimulated in vitro with anti-CD3 plus anti-CD28 for 24 h. Listeria infection of BALB/c mice induced IFN-γ production in an IL-12-dependent manner as the Il12b gene-targeted mice did not produce IFN-γ. On the other hand, Listeria infection of IRF-1-deficient mice induced IFN-γ production, suggesting the existence of an IRF-1-independent IL-12 production pathway (35) . Listeria infection of BALB/c mice inhibited IL-4 production, and this inhibition was independent of IL-12, but required IRF-1. Therefore, IRF-1 appears to function in regulating the T h -subset balance by inducing IL-12 production and inhibiting IL-4 production.
A soluble factor from Lm-infected spleen cells inhibits the IL-4 production by T h 2 cells
Cytokine production by the T-cell clones was unaffected by direct infection with Listeria. However, Listeria infection of the mixture of T h 2 T cells and T-depleted spleen cells resulted in the inhibition of IL-4 production, while the Lm infection only weakly affected the response of the T h 1 T cells (data not shown).
These observations suggest that the Lm-infected spleen cells secrete a soluble factor to inhibit the production of IL-4 by T cells. This possibility was directly tested in the experiment shown in Fig. 2A . The IL-4 production by MS-SB (T h 2 clone) cells could be inhibited by the Lm-infected culture supernatant (LmSN) of T-depleted spleen cells, indicating that the inhibition is mediated by a soluble factor secreted by the Lm-infected T-depleted spleen cells. IL-5-production was not inhibited. The IL-4-production of other T h 2 clones (8-5T clone and 24-2M clone) was also inhibited by LmSN (Fig. 2B) . The inhibitory effect of the LmSN was not observed with T h 1 cells (Fig. 2B) .
We next determined whether the inhibitory effect of LmSN is also observed with primary T cells. LmSN inhibited the IL-4-production but not IL-5-production by primary CD4 + T cells of B6 mice induced under T h 2 induction conditions in vitro. The IFN-γ production of primary T cells was not inhibited (Fig. 2C ). The results demonstrate that the LmSN inhibits the IL-4-production but not IL-5-production by primary IL-4 (ng ml-1) IFN-(ng ml-1) 28-4M (T h 1)
IL-4 (ng ml-1) 5 of the indicated cells were cultured in 48-well plates in the presence or absence of the LmSN (3%) that had been prepared as described. On the next day, the cultures were stimulated with P/I or plate-coated anti-TCRβ. The amounts of IL-4, IFN-γ and IL-5 in the culture supernatants were determined by ELISA on the following day. The data are shown as the mean + SEM of quadruplicates in one of five (A) and four (B) independent experiments. Statistical analysis was performed by using the t-test. ***P < 0.001, ns, P > 0.2. (C) Primary T h 2 and T h 1 cells were induced from CD4 + T cells of B6 mice and were used as responders. The indicated primary CD4 + T cells were cultured in the presence of the LmSN. On the next day, the cultures were stimulated with plate-coated anti-TCRβ antibody. The amounts of IL-4, IL-5 and IFN-γ in the culture supernatants were determined by ELISA. The data are shown as the mean + SEM of triplicates in one of three independent experiments. Statistical analysis was performed by using the t-test. **P < 0.01, ns, P > 0.1.
T cells as well as T h -cell clones. As the observed inhibitory effect of the LmSN appeared to be specific for IL-4, we focused on the effect of LmSN on IL-4 responses in the further study.
The transcription of the Il4 gene is inhibited by LmSN treatment
To understand the involvement of IRF-1 in the observed inhibitory effect on IL-4-production, we cultured MS-SB cells and primary CD4 + T cells of DO11.10 Tg mice in the presence or absence of the LmSN from T-depleted spleen cells followed by the stimulation or without stimulation (Fig. 3) . Stimulation of MS-SB cells and primary CD4 + T cells increased the levels of IL-4 mRNA, but the addition of LmSN led to inhibition of IL-4 mRNA expression. The levels of IL-5 and IL-13 transcripts were slightly affected or unaffected by the addition of LmSN. On the other hand, the expression of IRF-1 was reduced by stimulation with P/I or anti-TCRβ antibody. Interestingly, the expression of IRF-1 was not reduced when the stimulation was done in the presence of the LmSN.
To evaluate whether the inhibition of IL-4 mRNA expression is due to the inhibition of transcription, we assessed the level of the pre-mRNA of the Il4 gene. As shown in Fig. 3 , the levels of pre-IL-4 mRNA were also reduced in the group treated with the LmSN. Therefore, the transcription of the Il4 gene is inhibited in MS-SB cells and primary CD4 + T cells treated with the LmSN.
IL-1 is an active molecule in the LmSN that inhibits the IL-4 production by T h 2 cells
To identify the nature of the molecule in the LmSN that inhibits IL-4 production by T h 2 cells, we evaluated several proinflammatory and inflammatory cytokines including IFN-β, IFN-γ, LIF, M-CSF, GM-CSF, TNF-α, IL-6, IL-12, IL-15 and IL-23 and found no inhibition of IL-4 production with any of them; however, the inhibitory effect on MS-SB cells was clearly observed with IL-1β (data not shown). The addition of recombinant IL-1α and IL-1β inhibited the expression of the Il4 gene (Fig. 4A) .
To evaluate whether IL-1 is an active molecule of LmSN that inhibits IL-4-production by T h 2 cells, we carried out a neutralization experiment using anti-IL-1α antibody and anti-IL-1β antibody. Although anti-IL-1α antibody and anti-IL-1β antibody partially neutralized the LmSN activity, the mixture of these two antibodies completely neutralized the inhibitory activity of LmSN (Fig. 4A) . A neutralization experiment with the anti-IL-1R antibody further confirmed that IL-1 mediates the inhibitory effect of the LmSN through IL-1R (Fig. 4B) .
Treatment of MS-SB cells with the recombinant IL-1β increased IRF-1 protein in the cytosol and nucleus, suggesting that the treatment induces the stabilization and/or nuclear translocation of IRF-1 ( Fig. 4C and D) . These results demonstrate that IL-1α and IL1β are active molecules in the LmSN that induce the stabilization and/or nuclear translocation of IRF-1 to inhibit Il4 gene expression by MS-SB cells.
Il4 gene transcription is inhibited by IRF-1
To further determine whether IRF-1 inhibits the transcription of Il4 in T h 2 cells, MS-SB cells were transfected with the pAct-1 plasmid, which is a murine IRF-1 expression plasmid with an actin promoter, or left untreated. The cells were stimulated on the next day with P/I. The amount of IL-4 but not IL-5 production by the MS-SB cells was inhibited in the presence of exogenous IRF-1 (Fig. 5A) .
To test whether exogenous IRF-1 directly inhibits the Il4 gene promoter activity, MS-SB cells were transfected with a luciferase reporter plasmid containing the Il4 gene promoter region (pIL4-pGL4) and pAct-1. If exogenous IRF-1 inhibits the Il4 promoter activity, the luciferase activity would be decreased in this setting. As shown in Fig. 5B , pAct-1 (IRF-1) inhibits IL-4 production without affecting luciferase activity. The addition of LmSN to the cultures inhibited IL-4 production but failed to inhibit luciferase activity. Although this result is compatible with post-transcriptional effects, the results in Fig. 3 strongly suggest that the effect is on transcription of the recombinant IL-1β for 1 day, stimulated with or without P/I, and the cytosol and nuclear lysate was prepared and IRF-1 protein was detected by western blotting. Analysis of α-tubulin serves as a loading control (bottom). Results are representative of two independent experiments. Relative expression of nuclear and cytosolic IRF-1 was calculated from the pooled data of two independent experiments using the expression of α-tubulin as a loading control.
Il4 gene. Therefore, this result suggested the possibility that IRF-1 and LmSN inhibit Il4 gene transcription without affecting the promoter. The above data let us to hypothesize that IRF-1 binds to the 3ʹUTR region of the Il4 gene and regulates transcription of the gene during the Lm infection. To test this possibility, the 3ʹUTR region of the Il4 gene was inserted downstream of the pIL4-pGL4 luciferase reporter plasmid (pIL4-pGL4-3ʹUTR). Co-transfection of pAct-1 with pIL4-pGL4-3ʹUTR inhibited luciferase activity and IL-4 production; addition of LmSN to the cultures suppressed both (Fig. 5C ). This result is consistent with the idea that the 3ʹUTR region plays an important role in inhibiting transcription of the Il4 gene during the Lm infection.
Taken together, the data suggest that IRF-1 interacts with the 3ʹUTR region of the Il4 gene to inhibit the transcription of the gene during the Lm infection. This possibility was tested by the ChIP assay (Fig. 6) . The anti-IRF-1 antibody precipitated the 3ʹUTR region of the Il4 gene from MS-SB cells that had been cultured with the LmSN. This result demonstrated that IRF-1 binds to the 3ʹUTR region of the Il4 gene, and further suggested that, under the influence of Lm infection, IRF-1 functions to inhibit gene transcription.
IL-1 inhibits the IL-4-production by primary T cells of WT but not IRF-1-deficient mouse
As IRF-1 seems to be involved in the inhibition of IL-4-production mediated by LmSN/IL-1, we determined whether this activity of LmSN/IL-1 is mediated by IRF-1 in primary T cells (Fig. 7) . LmSN inhibited the IL-4-production by primary T h 2 cells of B6 mice and the littermates of IRF-1-deficient mice, but that of IRF-1-deficient mouse T h 2 cells was not inhibited; indicating that the failure of inhibition of IL-4-production in IRF-1-deficient mice is due to the T-cell intrinsic nature of the IRF-1 defect (Fig. 7A) . It was further confirmed that IRF-1 is involved in the inhibition of IL-4-production mediated by IL-1β (Fig. 7B) . Therefore, IRF-1 is required for IL-1β-mediated inhibition of IL-4-production by T h 2 cells.
The LmSN inhibits T h 2 cell differentiation of primary T cells
To determine whether the LmSN influences T h -subset differentiation in vitro, spleen cells of DO11.10 OVA-TCR transgenic mice were stimulated with nominal antigen for 5 days in the presence or absence of the LmSN. As shown in Fig. 8A , addition of the LmSN inhibited the production of IL-4 without affecting the T h 1 response. The expression of GATA3 mRNA was also reduced, although T-bet was unaffected (Fig. 8B) . These results indicate that differentiation of the T h 2 subset is inhibited by in vitro treatment with LmSN. In addition, the neutralization experiments demonstrated that the LmSN induced inhibition of IL-4 production and GATA3 expression by DO11.10 cells is dependent on IL-1 (Fig. 8) .
We next determined whether LmSN influences T h -subset differentiation in vivo. Spleen cells of the LmSN-injected BALB/c mice were stimulated in vitro with anti-CD3 plus anti-CD28 for 1 day, and the amounts of IL-4 and IFN-γ produced in the cultures were measured. As shown in Fig. 8C , IL-4 production in the spleen cell cultures of LmSN-treated mice was profoundly inhibited without affecting IFN-γ production. The ratio of IL-4/IFN-γ was reduced in the LmSN-treated mice, suggesting the shift to a T h 1 dominant status in the treated mice. Thus, the LmSN was controlling the T-cell subset differentiation in vivo as well.
Discussion
Here, we have identified a novel function of the IRF-1 transcription factor in controlling the T h -cell subset balance during pathogen infection and have demonstrated that IL-1 in the LmSN negatively regulates transcription of the Il4 gene through IRF-1 binding to its 3ʹUTR. The pathogen infection induces the shift in T h -subset balance to the T h 1 dominant state by augmenting the production of IL-12. The activation of the Il12b gene is mainly controlled by IRF-1 and NF-κB in dendritic cells (DCs) and macrophages (10, 11) . Thus, IRF-1 has been recognized as an important factor regulating differentiation of the T h 1 subset. Experiments utilizing Il12b and Irf1 gene-targeted mice revealed the other side of IRF-1's functions. The response pattern suggested that the T h 2 subset inhibition that occurs during pathogen infection is not simply a mirror image of T h 1-subset induction, rather that the inhibition is an active process involving IRF-1but not IL-12. Although IRF-1 is thought to function in innate immune cells during pathogen infections (21) , this study demonstrated that IRF-1 also functions in T cells to negatively regulate cytokine production.
IRF-1 is involved in many aspects of the innate and adaptive immune responses (21, 36) . In the context of the lineage differentiation of CD4 + T cells, it has been reported that IRF-1 plays a critical role in the expression of Il12b in APCs (10) . By contrast, the function of IRF-1 in CD4 + T cells has remained poorly understood, except for a few in vitro observations (20, 37) . IRF-1 mRNA is expressed at a high level in resting T h 2 cells and is down-regulated in the activated state, an expression pattern different from that of DCs and macrophages where transcription of the Irf1 gene is induced by stimulation. The protein level of IRF-1 in the cytosolic fraction was slightly reduced by stimulation with P/I, although the mRNA was significantly reduced. Though the reason for this discrepancy is not known, it might be possible that the stability of the IRF-1 protein in T cells is different from that in macrophage/ DC cells. This suggests that transcription of the Irf1 gene is regulated by different mechanisms among these cell types. In addition, we demonstrated that IL-1 induces the translocation and/or stabilization of IRF-1 protein in the nucleus of T cells. It is also reported that IL-1 induces IRF-1 in several non-lymphoid cells (38, 39) , and T h 9 cells in which IRF-1 enhanced secretion of IL-9 and IL-21 (40) .
It was reported that IRF-1 binds to the Il4 promoter and functions as a transcriptional repressor (20) . However, we failed to detect any suppressive effect of IRF-1 on the Il4 promoter in reporter construct experiments. Instead, the 3ʹUTR region of the Il4 gene is required for the inhibitory effect of IRF-1 and IRF-1 binds to this region in the ChIP assay. On the basis of these results, we conclude that the LmSN directly suppresses Il4 gene expression by inducing IRF-1 binding to the 3ʹUTR region. The precise mechanism of IRF-1 binding to the 3ʹUTR region needs to be clarified.
Lm infection induces T h 1 responses in vivo and in vitro. On the other hand, the LmSN inhibits IL-4-production without affecting IFN-γ-production when added to cultures of DO11.10 spleen cells, indicating that the differentiation of the T h 2 subset is inhibited by treatment with the LmSN in vitro. The LmSN inhibits the induction of GATA3 following TCR stimulation, suggesting that the LmSN inhibits the induction of T h 2-specific genes and T h 2 differentiation (41, 42) . Thus, the LmSN inhibits both the differentiation of naive T cells to the T h 2 subset and the function of already differentiated T h 2 cells.
We found a discrepancy between the effects on T h 1 cells of Lm infection versus the LmSN treatment. Notably, the LmSN treatment failed to induce T h 1 differentiation and activation, although Lm infection strongly induces a T h 1 response. Infection with Lm changes the nature of APCs and that influences T-cell subset differentiation (27) . Therefore, additional Statistical analysis was performed by using t-test. **P < 0.01, ***P < 0.001, ns, P > 0. 2. components in addition to the LmSN are likely to be required for inducing the T h 1 response. This may suggest that the T h 1-inducing activity requires cognate interaction between the Lm infected-DC and T cells in addition to the LmSN. We are especially interested in the role of Tnfsf/Tnfrsf members in this process, as they function as a co-stimulatory molecules in T-cell responses (43, 44) , a relationship that will be clarified in future experiments.
On the basis of our new findings, we propose that IRF-1 functions to induce the T h 1 shift via two distinct mechanisms, the previously known mechanism and a novel one described here. IRF-1 activates the Il12b gene promoter and induces its transcription, resulting in a shift to the T h 1 subset (10) (11) (12) 21) . In addition, under the influence of IL-1, IRF-1 binds the 3ʹUTR region and inhibits transcription of the Il4 gene in T h 2 cells. Therefore, the immune system shifts predominantly to T h 1 responses during Listeria infection, resulting in effective protection of the host from the pathogen. The cytokine levels were determined by ELISA on the next day. The data are shown as the mean + SEM of triplicates in one of three independent experiments. Statistical analysis was performed by using the t-test. ***P < 0.001, ns, P > 0.1. (B) Spleen cells from DO11.10 Tg mice were stimulated in vitro as in (A). After 5 days of cultivation, the expression of the indicated mRNA was determined by qPCR. β-Actin was used as a loading control. The data are shown as the mean + SEM of triplicates in one of three independent experiments. Statistical analysis was performed by using the t-test. **P < 0.01, ns, P > 0.2. (C) BALB/c mice were intra-peritoneally injected with 0.5 ml of the LmSN and 5 days later spleen cells of the treated and untreated control mice were stimulated in vitro with anti-CD3 plus anti-CD28. The cytokine levels were determined by ELISA on the next day. The relative ratio of IL-4 and IFN-γ is also shown. The pooled data of two independent experiments are shown with the mean value. Statistical analysis was performed by using the t-test, ns, P > 0.2.
